1 – 50 of 307
- show: 50
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
- Assessing Automated Sample Preparation Technologies for High-Throughput Proteomics of Frozen Well Characterized Tissues from Swedish Biobanks (
- Stromal fibronectin expression in patients with resected pancreatic ductal adenocarcinoma (
- 2018
- Intraductal Papillary Mucinous Neoplasms of the Pancreas : A Nationwide Registry-Based Study (
- Targeting dendritic cells in pancreatic ductal adenocarcinoma (
- Pancreatic cancer : Disease dynamics, tumor biology and the role of the microenvironment (
- Parenchyma-sparing hepatectomy (PSH) versus non-PSH for bilobar liver metastases of colorectal cancer (
- Intratumoural leukocyte infiltration is a prognostic indicator among pancreatic cancer patients with type 2 diabetes (
- Centrosomal Abnormalities in Pancreatic Cancer : Molecular Mechanisms and Clinical Implications (
- The prognostic role of cancer stem cell markers for long-term outcome after resection of colonic liver metastases (
- Selektiv nivåstrukturering av svensk kirurgi behövs (
- High-density and targeted glycoproteomic profiling of serum proteins in pancreatic cancer and intraductal papillary mucinous neoplasm (
- Quantitative Assessment of Urea In-Solution Lys-C/Trypsin Digestions Reveals Superior Performance at Room Temperature over Traditional Proteolysis at 37 °C. (
- Immunohistochemical investigation of prognostic biomarkers in resected colorectal liver metastases : A systematic review and meta-analysis (
- Calcium-activated chloride channel regulator 1 as a prognostic biomarker in pancreatic ductal adenocarcinoma (
- Intraductal papillary mucinous neoplasms of the pancreas – a cost-effectiveness analysis of management strategies for the branch-duct subtype (
- Galectin 4 is a biomarker for early recurrence and death after surgical resection for pancreatic ductal adenocarcinoma (
- Sustainability of an Enhanced Recovery Program for Pancreaticoduodenectomy with Pancreaticogastrostomy (
- Thymidylate synthase : A predictive biomarker in resected colorectal liver metastases receiving 5-FU treatment (
- Proteomic analyses identify prognostic biomarkers for pancreatic ductal adenocarcinoma (
- 2017
- Development and In Vitro Characterization of a Gemcitabine-loaded MUC4-targeted Immunoliposome Against Pancreatic Ductal Adenocarcinoma (
- The role of irreversible electroporation (IRE) for locally advanced pancreatic cancer : a systematic review of safety and efficacy (
- Outcome and evaluation of prognostic factors after pancreaticoduodenectomy for distal cholangiocarcinoma (
- Pankreascancer kan metastasera tidigt : Tumörbiologi tycks viktigare än tumörstorlek (
- Relationship between tumour size and outcome in pancreatic ductal adenocarcinoma (
- Dietary fibre for the prevention of recurrent colorectal adenomas and carcinomas (
- Postoperative pancreatic fistula-impact on outcome, hospital cost and effects of centralization (
- Pancreatic cancer stroma : controversies and current insights (
- The 2016 update of the International Study Group (ISGPS) definition and grading of postoperative pancreatic fistula : 11 Years After (
- Biomarkers, imaging and multifocality in intraductal papillary mucinous neoplasms : Relevant for decision making? (
- Hemorrhage after Major Pancreatic Resection: Incidence, Risk Factors, Management, and Outcome. (
- Does next-generation sequencing of cyst fluid improve management of pancreatic cystic neoplasms? (
- Epigenetic alterations as biomarkers in pancreatic ductal adenocarcinoma (
- The challenges of centralization with HPB resectional surgery (
- Characterization of histone-related chemical modifications in formalin-fixed paraffin-embedded and fresh-frozen human pancreatic cancer xenografts using LC-MS/MS (
- Involvement of the PI3K/Akt/NF- B Signaling Pathway in the Attenuation of Severe Acute Pancreatitis-Associated Acute Lung Injury by Sedum sarmentosum Bunge Extract (
- Can protein science solve the unmet needs in pancreatic cancer diagnosis and therapy? (
- Predictors of incidental gallbladder cancer in patients undergoing cholecystectomy for benign gallbladder disease : Results from a population-based gallstone surgery registry (
- Acute biliary pancreatitis: focus on recurrence rate and costs when current guidelines are not complied (
- Impact of body constitution on complications following pancreaticoduodenectomy : A retrospective cohort study (
- Pancreatic ductal adenocarcinoma : Is a cure possible? (
- Histone profiling reveals the H1.3 histone variant as a prognostic biomarker for pancreatic ductal adenocarcinoma (
- Intraductal papillary mucinous neoplasm of the pancreas–epidemiology, risk factors, diagnosis, and management (
- Changing management of gallstone-related disease in pregnancy–a retrospective cohort analysis (
- Low MUC4 expression is associated with survival benefit in patients with resectable pancreatic cancer receiving adjuvant gemcitabine (
- 2016
- Combining gas-phase electrophoretic mobility molecular analysis (GEMMA), light scattering, field flow fractionation and cryo electron microscopy in a multidimensional approach to characterize liposomal carrier vesicles (
- Pattern of tumour growth of the primary colon cancer predicts long-term outcome after resection of liver metastases (
- Pancreatic cancer : Yesterday, today and tomorrow (
- Impact by pancreatic stellate cells on epithelial-mesenchymal transition and pancreatic cancer cell invasion : Adding a third dimension in vitro (
- Cholangiocarcinoma - current classification and challenges towards personalised medicine. (
- Nano electrospray gas-phase electrophoretic mobility molecular analysis (nES GEMMA) of liposomes : Applicability of the technique for nano vesicle batch control (